Profile_bird

Hey there! fardj is using Twitter.

Twitter is a free service that lets you keep in touch with people through the exchange of quick, frequent answers to one simple question: What are you doing? Join today to start receiving fardj's tweets.

Already using Twitter
from your phone? Click here.

fardj

  1. @pjmachado @JosJoseph @SusannahFox thanks for RTs of my post re: digital divide: http://twurl.nl/dqv2g1 about 11 hours ago from TweetDeck
  2. @TobyDiva @skypen here, here re: our '06 Vegas trip. My, my how the world has changed, or NOT changed depending on your perspective. :). about 11 hours ago from TweetDeck in reply to TobyDiva
  3. @richmeyer ok. thanks. about 16 hours ago from TweetDeck in reply to richmeyer
  4. @richmeyer oh, sorry about that. you were referring to the data from @skypen. what's the source of your research? about 16 hours ago from TweetDeck in reply to richmeyer
  5. @richmeyer i'm sorry, I'm not sure what you're referring to. about 16 hours ago from TweetDeck in reply to richmeyer
  6. 27% of those visiting drug sites viewed info re: side effects: http://bit.ly/19lSxN qs remain re: comprehension of risk info #fdasm about 16 hours ago from TweetDeck
  7. many thanks to @skypen for developing www.fdasm. fantastic resource, great innovation + crowdsourcing. #fdasm about 16 hours ago from TweetDeck
  8. Congrats! RT @skypen: Ignite Health wins silver CLIO 4 best DTC digital campaign www.livewitit.com, top prize http://yfrog.com/5dhmmthj 5:38 AM Nov 14th from Echofon
  9. We're going to do more advanced research on some of the issues I mentioned during my talk in time for FDA Feb deadline. Stay tuned. 10:07 AM Nov 13th from Echofon
  10. I'd like to thank everyone for their kind words re: my presentation at #fdasm yesterday. I hope FDA puts people first while moving fwd. 10:05 AM Nov 13th from Echofon
  11. @ChristianeTrue thanks for your tweet re: my presentation. You can find a link to my slides at fdasm.com (using the Google doc link) 9:59 AM Nov 13th from Echofon in reply to ChristianeTrue
  12. I'm done adding notes for my preso. Now, back to the abode. I'll see everyone tomorrow at the hearing. #fdasm. 2:38 PM Nov 11th from TweetDeck
  13. @sarahmorgan thanks for the best wishes! looking forward to seeing everyone tomorrow at hearing. #fdasm 9:06 AM Nov 11th from TweetDeck in reply to sarahmorgan
  14. RT @shwen: #SocPharm See + discuss #fdaSM preso's by @pharmaguy @fardj @MelissaKDavies @healthyjack on SocialPharmer (http://bit.ly/2ghC08) 6:48 AM Nov 6th from TweetDeck
  15. @ePatientDave 5 is enough to identify major issues. Addtl research can be done to dog deeper. Low n qualitative res can provide grt value. 3:32 PM Nov 4th from Echofon in reply to ePatientDave
  16. @ePatientDave I'm answering the question from my acct. It jibes w/ other studies lking at how people search and how they process web info. 3:30 PM Nov 4th from Echofon in reply to ePatientDave
  17. will scope be about what I outlined? 8:35 AM Nov 3rd from txt
  18. @jonmrich yep, but we were also talking about the big distinction Btwn marketing with social tools and social marketing 7:18 AM Oct 31st from Echofon in reply to jonmrich
  19. @cindythroop @DaphneLeigh @meredithgould I'm game. But know that I believe the terms we use matter, especially in the case of social mrktg 6:32 AM Oct 31st from Echofon
  20. @DaphneLeigh @cindythroop it's not jargon. Social marketing has been around since the 70s read this http://tinyurl.com/l5c256 6:21 AM Oct 31st from Echofon in reply to DaphneLeigh